Myeloid Sarcomas Causing Unilateral Cranial Nerve Palsies in a Patient with Relapsed Acute Myeloblastic Leukemia

Case Reports in Hematology
A Mendez-HernandezL Sumoza

Abstract

Myeloid sarcomas (MS) are a rare manifestation of myeloid malignancies and can often be misdiagnosed, leading to a delay in treatment. The objective of this clinical case is to highlight the challenges of the clinical presentation and to emphasize the importance of this manifestation ensuring timely diagnosis and therapy. Here, we present a 43-year-old man who was diagnosed with acute myeloblastic leukemia (AML) after being evaluated for unintentional weight loss, subcutaneous nodules, thrombocytopenia, and anemia. The patient underwent chemotherapy with complete remission and presented 4 months later with dysphagia and cranial nerve palsies. Appropriate imaging and biopsy led to a diagnosis of myeloid sarcoma, and a decision was made to begin reinduction chemotherapy for AML achieving a second complete remission although his neurological deficits did not improve. Our case illustrates the protean presentation of myeloid sarcomas; clinicians should have a high suspicion for MS and remain vigilant when unexplained signs and symptoms arise in the background of a myeloid malignancy although challenges still remain when presentation is de novo. Advancements in understanding the pathophysiology of MS have been performed but remain no...Continue Reading

References

Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C ByrdC D Bloomfield
Nov 8, 2001·Archives of Pathology & Laboratory Medicine·J ChenN S Aguilera
Jul 29, 2009·Blood·Michael StefanidakisErkki Koivunen
Jul 29, 2011·Blood·Richard L BakstJoachim Yahalom
Jan 1, 2011·Leukemia Research and Treatment·Hani Al-KhateebSalah Abbasi
Oct 1, 2011·Therapeutic Advances in Hematology·Batia Avni, Maya Koren-Michowitz
Oct 24, 2013·Radiation Oncology·Wan-Yu ChenAnn-Lii Cheng
Apr 29, 2016·Oncology Letters·Xin WangSheng-Xiang Xiao
Nov 21, 2017·Clinical Case Reports·Dorothy Mitkowski, Lidia Gil

❮ Previous
Next ❯

Methods Mentioned

BETA
bone
biopsy

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

World Journal of Gastroenterology : WJG
Xiao-Li HuangBin Wu
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Sung Won LimChan Kum Park
Journal français d'ophtalmologie
J-B DucloyerJ-B Deltour
© 2022 Meta ULC. All rights reserved